Skip to main content

Table 2 Procedural Characteristics

From: Early hemodynamic performance of the Trifecta™ surgical bioprosthesis aortic valve in Indian patient population: 12 month outcomes of the EVEREST post-market study

 

All (n = 100)

Cardiopulmonary bypass time (min)

112.1 ± 49.23 (98)

Aortic cross clamp time (min)

78.35 ± 33.77 (98)

Suture technique, n (%)

 Simple interrupted

51/100 (51%)

 Continuous

3/100 (3%)

 Everting mattress

7/100 (7%)

 Non-everting mattress

22/100 (22%)

 Other

18/100 (18%)

Concomitant surgical procedure, n (%)

 Coronary artery bypass graphing

28/100 (28%)

 Mitral valve repair

2/100 (2%)

 Other

3/100 (3%)

Implanted valve size

 19 mm

36

 21 mm

45

 23 mm

13

 25 mm

5

 27 mm

1

  1. n Total number of patients, min Minutes, mm Millimeter